IS Pharma goes for growth

Sorry your web browser is not fully supported.

Unfortunately Internet Explorer 7 and below have issues with web standards which will affect most modern websites and applications.
We recommend that you make the switch to a compliant browser such as FireFox, Safari, Google Chrome or Internet Explorer 8.

By Real Deals, published 1 year ago in Finance & Banking.

Chester-based medical devices business gets a major boost.

More from this section

Bank of Scotland Corporate is to provide AIM-listed IS Pharma with a facility worth £8m (€10m) to fund the company’s continued growth and acquisition plans.

IS Pharma is a late-stage pharmaceuticals and medical devices business in the specialist hospital medicine sector, with a current focus on critical care, neurology and oncology.

The Chester-based company recently acquired Swiss pharmaceuticals group, Speciality European Pharmaceuticals, for £9.25m.

IS Pharma, previously Maelor, adopted its new name following the acquisition, which has given it a new portfolio of specialist hospital pharmaceutical products.

| More

Comment are closed for this article.

Most

Read

Commented

Searched

Editor's Comment

By Matthew Rock.

I've discovered the biggest General Election issue that won't get discussed. It's costing us somewhere between £60bn and £140bn.... Read this comment in full »

Read all comments »

Real Business